All

What are you looking for?

All
Projects
Results
Organizations

Quick search

  • Projects supported by TA ČR
  • Excellent projects
  • Projects with the highest public support
  • Current projects

Smart search

  • That is how I find a specific +word
  • That is how I leave the -word out of the results
  • “That is how I can find the whole phrase”

Aminopeptidase N: a multifunctional and promising target in medicinal chemistry

The result's identifiers

  • Result code in IS VaVaI

    <a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00216224%3A14160%2F25%3A00143705" target="_blank" >RIV/00216224:14160/25:00143705 - isvavai.cz</a>

  • Result on the web

    <a href="https://pubs.rsc.org/en/content/articlelanding/2025/ra/d5ra03038b" target="_blank" >https://pubs.rsc.org/en/content/articlelanding/2025/ra/d5ra03038b</a>

  • DOI - Digital Object Identifier

    <a href="http://dx.doi.org/10.1039/d5ra03038b" target="_blank" >10.1039/d5ra03038b</a>

Alternative languages

  • Result language

    angličtina

  • Original language name

    Aminopeptidase N: a multifunctional and promising target in medicinal chemistry

  • Original language description

    Aminopeptidase N (APN) is a zinc metalloproteinase present in almost all types of organisms and has various functions. Many of them are unrelated to its catalytic activity, which is why APN is sometimes classified as a moonlighting enzyme. APN is involved in carcinogenesis and angiogenesis. It also works as an entrance receptor for some coronaviruses and acts as a mediator during skin inflammation. Additionally, APN removes and helps to recycle regulatory proteins including neuropeptides, which is why its inhibitors hold therapeutic potential for a wide range of diseases, making the design and development of such molecules highly desirable. Some of them, such as bestatin or tosedostat, have already been tested as therapeutics with partial success. This article aims to bring an overview of multiple APN functions and implications for various diseases and their inhibitors which have already been prepared, and to suggest areas where the development of inhibitors may be promising in the future.

  • Czech name

  • Czech description

Classification

  • Type

    J<sub>imp</sub> - Article in a specialist periodical, which is included in the Web of Science database

  • CEP classification

  • OECD FORD branch

    30107 - Medicinal chemistry

Result continuities

  • Project

  • Continuities

    S - Specificky vyzkum na vysokych skolach

Others

  • Publication year

    2025

  • Confidentiality

    S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

Data specific for result type

  • Name of the periodical

    RSC ADVANCES

  • ISSN

    2046-2069

  • e-ISSN

    2046-2069

  • Volume of the periodical

    15

  • Issue of the periodical within the volume

    32

  • Country of publishing house

    GB - UNITED KINGDOM

  • Number of pages

    18

  • Pages from-to

    26455-26472

  • UT code for WoS article

    001534076900001

  • EID of the result in the Scopus database

    2-s2.0-105011612473